Friday, 19 Oct 2018

You are here

Daniel Lovell, MD: abatacept in JIA

Dr. Daniel Lovell, a pediatric rheumatologist from the University of Cincinnati/Cincinnati Children's Hospital Medical Center discusses a phase-4 study looking at the effectiveness and safety of abatacept in kids with JIA.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Phil Aleksiejuk: Drug-Induced ANCA...

09 Feb 2018

RWCS 2017: Hydralazine-Induced ANCA-...

21 Feb 2017

The RheumNow Week in Review – 13...

13 Jan 2017

The RheumNow Week in Review – 11 August...

11 Aug 2017

The RheumNow Week in Review – Life...

29 Jun 2018

Dr. Paul Sufka: Rheumatology Journal...

05 Nov 2017

How to Use RheumNow.com

26 Sep 2016

The ACR17 RheumNow Week in Review - 1...

01 Dec 2017

Dr. Kathryn Dao: Evidence of Prior...

06 Nov 2017

Dr. Rachel Tate: Ultrasound Education

08 Nov 2017

The RheumNow Week in Review - 19...

19 Jan 2018

The RheumNow Week in Review – 28 July...

28 Jul 2017